Evidence map›Paper›PMID 41908067›Full record

ArticleRegenerative biomaterials2026

Zn ion-implanted absorbable Fe for improved cytocompatibility and mitigated neointimal hyperplasia.

Xueying Wang, Hongyi Liu, Mingjiang Sun, Aihua Liu, Yan Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Regenerative biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xueying WangSchool of Materials Science and Engineering, Beihang University, Beijing 100191, China.
Hongyi LiuBeijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Mingjiang SunBeijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Aihua LiuBeijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Yan LiSchool of Materials Science and Engineering, Beihang University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-5610-5341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ultrathin strut Fe-based scaffolds have made significant progress in the field of vascular interventional devices, but the issues of slow degradation and insufficient biocompatibility at the cell/material interface remain unresolved. This study prepared a functionalized surface on Fe by Zn ion implantation (Zn/Fe). Zn/Fe preferentially releases the antioxidant element Zn in the early degradation due to Zn-Fe galvanic coupling corrosion. It facilitates the adhesion and proliferation of endothelial cells and mitigates the risk of oxidative stress. The degradation rate of Zn/Fe was about 1.6 times that of Fe after 56 days of implantation in the common carotid artery of rats, with a 36.1% reduction in lumen loss rate, demonstrating favorable

Indexed as

biodegradableFe-based alloyion implantationneointimal hyperplasiazinc

Identifiers

PMID41908067
PMCPMC13020250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.